Gene · 6422
Papers4,318
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,318
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis. | Int J Mol Sci | 2023 | 38068961 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review. | Cancers (Basel) | 2023 | 38067304 | PubTator, text mining | PubMed |
| Novel urine cell-free DNA methylation markers for hepatocellular carcinoma. | Sci Rep | 2023 | 38062093 | PubTator, text mining | PubMed |
| Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression. | Clin Transl Med | 2023 | 38050190 | PubTator, text mining | PubMed |
| PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study. | Aging (Albany NY) | 2023 | 38048211 | PubTator, text mining | PubMed |
| The importance of BMPs and TGF-βs for endochondral bone repair - A longitudinal study in hip arthroplasty patients. | Bone Rep | 2023 | 38047271 | PubTator, text mining | PubMed |
| Patterns of de novo metastasis and survival outcomes by age in breast cancer patients: a SEER population-based study. | Front Endocrinol (Lausanne) | 2023 | 38027167 | PubTator, text mining | PubMed |
| A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up. | Front Oncol | 2023 | 38023177 | PubTator, text mining | PubMed |
| A prognostic risk model for programmed cell death and revealing TRIB3 as a promising apoptosis suppressor in renal cell carcinoma. | Aging (Albany NY) | 2023 | 38006403 | PubTator, text mining | PubMed |
| HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review Article. | Int J Mol Sci | 2023 | 38003240 | PubTator, text mining | PubMed |
| Molecular Biology and Clinical Management of Esophageal Adenocarcinoma. | Cancers (Basel) | 2023 | 38001670 | PubTator, text mining | PubMed |
| Spatiotemporal cellular dynamics and molecular regulation of tooth root ontogeny. | Int J Oral Sci | 2023 | 38001110 | PubTator, text mining | PubMed |
| Concentration of Secreted Frizzled-Related Proteins (SFRPs) in Non-Small Cell Lung Carcinoma Subtypes-A Preliminary Study. | Curr Oncol | 2023 | 37999144 | PubTator, text mining | PubMed |
| Deriving early single-rosette brain organoids from human pluripotent stem cells. | Stem Cell Reports | 2023 | 37995702 | PubTator, text mining | PubMed |
| Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer. | Curr Pharmacol Rep | 2023 | 37994344 | PubTator, text mining | PubMed |
| Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids. | Diseases | 2023 | 37987267 | PubTator, text mining | PubMed |
| Screening and identification of hub genes of scar physique via weighted gene co-expression network analysis. | Medicine (Baltimore) | 2023 | 37986383 | PubTator, text mining | PubMed |
| LINC01638 sustains human mesenchymal stem cell self-renewal and competency for osteogenic cell fate. | Sci Rep | 2023 | 37985890 | PubTator, text mining | PubMed |
| N-of-one differential gene expression without control samples using a deep generative model. | Genome Biol | 2023 | 37974217 | PubTator, text mining | PubMed |
| Biomarkers in renal cell carcinoma and their targeted therapies: a review. | Explor Target Antitumor Ther | 2023 | 37970211 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6422/papers?page=13